Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

2.72
Delayed Data
As of Aug 15
 +0.01 / +0.37%
Today’s Change
2.24
Today|||52-Week Range
59.99
-43.69%
Year-to-Date

Today’s Trading

Previous close2.71
Today’s open2.71
Day’s range2.64 - 2.74
Volume402,331
Average volume (3 months)682,146
Market cap$97.8M
Dividend yield--
Data as of 08/15/2017

Growth & Valuation

Earnings growth (last year)-78.10%
Earnings growth (this year)+106.77%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.16%
P/E ratioNM
Price/Sales3.37
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc-0.04-2.98%
MEIPMEI Pharma Inc-0.02-0.72%
ZFGNZafgen Inc+0.03+0.89%
GTXIGTX Inc+0.07+1.22%
Data as of 08/15/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)$2.35
Annual revenue (last year)$50.9M
Annual profit (last year)-$193.4M
Net profit margin-379.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Glenn P. Sblendorio
Chief Operating Officer &
Senior Vice President
Keith Westby
Corporate headquarters
New York, New York

Forecasts